Comparison of Three Techniques for Generation of Tolerogenic Dendritic Cells: siRNA, Oligonucleotide Antisense, and Antibody Blocking

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hybridoma

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hyb.2010.0060PMID 21087095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells.

  2010cited by this paper
• Tolerance Induction by CD40 Silenced Dendritic Cells through Antisense

  2009influential reference
• Translating costimulation blockade to the clinic: lessons learned from three pathways

  2009cited by this paper
• Functional analysis of the quantitative expression of a costimulatory molecule on dendritic cells using lentiviral vector-mediated RNA interference.

  2009cited by this paper
• The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.

  2009cited by this paper
• Immune modulation through RNA interference-mediated silencing of CD40 in dendritic cells.

  2009cited by this paper
• Costimulation blockade in autoimmunity and transplantation.

  2008cited by this paper
• CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL-10 ratio resulting in a strong T cell stimulatory capacity.

  2008cited by this paper
• Promises and Obstacles for the Blockade of CD40–CD40L Interactions in Allotransplantation

  2008cited by this paper
• RNA learns from antisense.

  2007cited by this paper
• Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival

  2007cited by this paper
• Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA

  2006cited by this paper
• Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi.

  2005cited by this paper
• Antisense‐ and RNA interference‐based therapeutic strategies in allergy

  2005cited by this paper
• Mechanisms of gene silencing by double-stranded RNA

  2004cited by this paper
• Small interference RNA modulation of IL‐10 in human monocyte‐derived dendritic cells enhances the Th1 response

  2004cited by this paper
• Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing.

  2004influential reference
• siRNAs: applications in functional genomics and potential as therapeutics

  2004cited by this paper
• CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes.

  2004cited by this paper
• Induction of RNA interference in dendritic cells

  2004cited by this paper
• Genomewide view of gene silencing by small interfering RNAs

  2003cited by this paper
• Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival

  2003cited by this paper
• Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction

  2003influential reference
• Approaches for the sequence-specific knockdown of mRNA

  2003cited by this paper
• Immune Modulation by Silencing IL-12 Production in Dendritic Cells Using Small Interfering RNA12

  2003cited by this paper
• Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function 1

  2003cited by this paper
• Comparison of the Suppressive Effects of Antisense Oligonucleotides and siRNAs Directed Against the Same Targets in Mammalian Cells

  2003cited by this paper
• Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs.

  2003cited by this paper
• Antisense technologies. Improvement through novel chemical modifications.

  2003cited by this paper
• Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.

  2003cited by this paper
• Novel antisense and peptide nucleic acid strategies for controlling gene expression.

  2002cited by this paper
• Clinically useful monoclonal antibodies in treatment.

  2002cited by this paper
• Small Interfering RNA-Mediated Gene Silencing in T Lymphocytes

  2002cited by this paper
• Small Interfering RNA-Mediated Gene Silencing in T Lymphocytes1

  2002cited by this paper
• Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.

  2002cited by this paper
• RNA interference

  2002cited by this paper
• Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.

  2002cited by this paper
• Dendritic cells in transplantation--friend or foe?

  2001cited by this paper
• The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity1

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process

  2000cited by this paper
• Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival1

  2000cited by this paper
• RNA Interference

  2000cited by this paper
• The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.

  2000cited by this paper
• Oligonucleotide therapeutics: clothing the emperor.

  1999cited by this paper
• Interleukin-12: a cytokine at the interface of inflammation and immunity.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

  1978cited by this paper
• Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen

  1975cited by this paper
• IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

  1973cited by this paper

• Lipid Nanoparticle-Mediated Cd14 siRNA Delivery Ameliorates the Acute Inflammatory Response to Intracortical Microelectrode Implantation.

  2026cites this paper
• Reflections on Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

  2020cites this paper
• Downregulation of mouse CCR3 by lentiviral shRNA inhibits proliferation and induces apoptosis of mouse eosinophils

  2016cites this paper
• Endosomal recognition of Lactococcus lactis G121 and its RNA by dendritic cells is key to its allergy‐protective effects

  2016cites this paper
• Silenciament gènic de CD40 en al•lo i autoimmunitat. Estudi de la resposta immuno inflamatòria en models animals

  2013cites this paper
• Generation of Tolerogenic Dendritic Cells for Cell Therapy in Multiple Sclerosis

  2012cites this paper
• Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cells.

  2012cites this paper
• Comparative study of clinical grade human tolerogenic dendritic cells

  2011cites this paper